NO20005060L - Krystallinske former av 1S-[1<alfa>(2S,3R), 9<alfa>]6,10- diokso-N-(2-etoksy-5-okso-tetrahydro-3-furanyl)-9[[(1- isokinolyl)karbonyl]amino]oktahydro-6H-piridazino[1,2- a][1,2]diazepin-1-karboksamid - Google Patents

Krystallinske former av 1S-[1<alfa>(2S*,3R*), 9<alfa>]6,10- diokso-N-(2-etoksy-5-okso-tetrahydro-3-furanyl)-9[[(1- isokinolyl)karbonyl]amino]oktahydro-6H-piridazino[1,2- a][1,2]diazepin-1-karboksamid

Info

Publication number: NO20005060L
Authority: NO; Norway
Prior art keywords: alpha; pyridazino; diazepine; octahydro; isoquinolyl
Prior art date: 1998-04-08

Application number

NO20005060A

Other languages

English (en)

Other versions

NO327995B1 (no

NO20005060D0 (no

Inventor

Jean-Yves Godard

Valerie Rognon

Original Assignee

Hoechst Marion Roussel Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-08

Filing date

2000-10-06

Publication date

2000-10-06

2000-10-06 Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc

2000-10-06 Publication of NO20005060D0 publication Critical patent/NO20005060D0/no

2000-10-06 Publication of NO20005060L publication Critical patent/NO20005060L/no

2009-11-02 Publication of NO327995B1 publication Critical patent/NO327995B1/no

Links

-1 2-ethoxy-5-oxo-tetrahydro-3-furanyl Chemical group 0.000 title 1
PPIXVPFGMODPHO-UHFFFAOYSA-N N'-(isoquinoline-1-carbonyl)-2,3,4,6,7,8,9,10-octahydro-1H-pyridazino[1,2-a]diazepine-4-carbohydrazide Chemical compound C1(CCCN2N1CCCCC2)C(=O)NNC(=O)C1=NC=CC2=CC=CC=C12 PPIXVPFGMODPHO-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Crystallography & Structural Chemistry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Peptides Or Proteins (AREA)

NO20005060A 1998-04-08 2000-10-06 Krystallinsk form av vannfritt 1S-[1alfa(2S*,3R*), 9alfa]6,10-diokso-N-(2-etoksy-5-okso-tetrahydro-3-furanyl)-9[[(1-isokinolyl)karbonyl]amino]oktahydro-6H-piridazino[1,2-a][1,2]diazepin-1-karboksamid (form A), fremgangsmate for fremstilling av denne, og anvendelse av den for fremstilling av et medikament NO327995B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9804367A FR2777279B1 (fr)	1998-04-08	1998-04-08	Nouvelles formes cristallines du 1s-[1alpha(2s,3r), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide
PCT/FR1999/000799 WO1999052935A1 (fr)	1998-04-08	1999-04-07	Formes cristallines du 1s-[1alpha (2s,3r),9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepine-1- carboxamide

Publications (3)

Publication Number	Publication Date
NO20005060D0 NO20005060D0 (no)	2000-10-06
NO20005060L true NO20005060L (no)	2000-10-06
NO327995B1 NO327995B1 (no)	2009-11-02

Family

ID=9524993

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20005060A NO327995B1 (no)	1998-04-08	2000-10-06	Krystallinsk form av vannfritt 1S-[1alfa(2S,3R), 9alfa]6,10-diokso-N-(2-etoksy-5-okso-tetrahydro-3-furanyl)-9[[(1-isokinolyl)karbonyl]amino]oktahydro-6H-piridazino[1,2-a][1,2]diazepin-1-karboksamid (form A), fremgangsmate for fremstilling av denne, og anvendelse av den for fremstilling av et medikament

Country Status (38)

Country	Link
US (2)	US6544977B1 (no)
EP (1)	EP1070083B1 (no)
JP (1)	JP2002511485A (no)
KR (1)	KR100582981B1 (no)
CN (1)	CN1202123C (no)
AP (1)	AP1734A (no)
AR (1)	AR018328A1 (no)
AT (1)	ATE315044T1 (no)
AU (1)	AU758042B2 (no)
BG (1)	BG64736B1 (no)
BR (1)	BR9909549A (no)
CA (1)	CA2325629C (no)
CU (1)	CU23055A3 (no)
CZ (1)	CZ299744B6 (no)
DE (1)	DE69929315T2 (no)
DK (1)	DK1070083T3 (no)
EA (1)	EA002761B1 (no)
EE (1)	EE04467B1 (no)
ES (1)	ES2253880T3 (no)
FR (1)	FR2777279B1 (no)
GE (1)	GEP20032974B (no)
HK (1)	HK1038575B (no)
HR (1)	HRP20000665B1 (no)
HU (1)	HU227561B1 (no)
ID (1)	ID26290A (no)
IL (2)	IL138818A (no)
ME (1)	ME01627B (no)
NO (1)	NO327995B1 (no)
NZ (1)	NZ507199A (no)
PL (1)	PL197016B1 (no)
RS (1)	RS49916B (no)
SI (1)	SI1070083T1 (no)
SK (1)	SK286267B6 (no)
TR (1)	TR200002914T2 (no)
TW (1)	TW522152B (no)
UA (1)	UA71563C2 (no)
WO (1)	WO1999052935A1 (no)
ZA (1)	ZA200005438B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT2044025E (pt) *	2006-06-30	2012-12-17	Novartis Ag	Derivados de quinolinona e suas composições farmacêuticas
AU2014277867B2 (en) *	2007-12-04	2016-11-03	Arbutus Biopharma Corporation	Targeting lipids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6204261B1 (en) *	1995-12-20	2001-03-20	Vertex Pharmaceuticals Incorporated	Inhibitors of interleukin-1β Converting enzyme inhibitors
US5552400A (en) *	1994-06-08	1996-09-03	Sterling Winthrop Inc.	Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors

1998
- 1998-04-08 FR FR9804367A patent/FR2777279B1/fr not_active Expired - Lifetime
1999
- 1999-03-15 TW TW088103966A patent/TW522152B/zh not_active IP Right Cessation
- 1999-03-30 AR ARP990101432A patent/AR018328A1/es active IP Right Grant
- 1999-04-07 GE GEAP19995614A patent/GEP20032974B/en unknown
- 1999-04-07 HU HU0101586A patent/HU227561B1/hu not_active IP Right Cessation
- 1999-04-07 HK HK02100107.8A patent/HK1038575B/zh not_active IP Right Cessation
- 1999-04-07 JP JP2000543491A patent/JP2002511485A/ja active Pending
- 1999-04-07 SK SK1488-2000A patent/SK286267B6/sk not_active IP Right Cessation
- 1999-04-07 HR HR20000665A patent/HRP20000665B1/xx not_active IP Right Cessation
- 1999-04-07 CZ CZ20003678A patent/CZ299744B6/cs not_active IP Right Cessation
- 1999-04-07 CA CA2325629A patent/CA2325629C/fr not_active Expired - Fee Related
- 1999-04-07 BR BR9909549-1A patent/BR9909549A/pt not_active Application Discontinuation
- 1999-04-07 PL PL343350A patent/PL197016B1/pl unknown
- 1999-04-07 EA EA200001047A patent/EA002761B1/ru not_active IP Right Cessation
- 1999-04-07 ID IDW20002015A patent/ID26290A/id unknown
- 1999-04-07 ME MEP-2000-608A patent/ME01627B/me unknown
- 1999-04-07 AT AT99911890T patent/ATE315044T1/de active
- 1999-04-07 KR KR1020007011159A patent/KR100582981B1/ko not_active Expired - Fee Related
- 1999-04-07 AP APAP/P/2000/001939A patent/AP1734A/en active
- 1999-04-07 NZ NZ507199A patent/NZ507199A/xx not_active IP Right Cessation
- 1999-04-07 CN CNB998071455A patent/CN1202123C/zh not_active Expired - Fee Related
- 1999-04-07 US US09/647,858 patent/US6544977B1/en not_active Expired - Lifetime
- 1999-04-07 RS YUP-608/00A patent/RS49916B/sr unknown
- 1999-04-07 DK DK99911890T patent/DK1070083T3/da active
- 1999-04-07 SI SI9930877T patent/SI1070083T1/sl unknown
- 1999-04-07 ES ES99911890T patent/ES2253880T3/es not_active Expired - Lifetime
- 1999-04-07 AU AU30416/99A patent/AU758042B2/en not_active Ceased
- 1999-04-07 TR TR2000/02914T patent/TR200002914T2/xx unknown
- 1999-04-07 CU CU20000213A patent/CU23055A3/es unknown
- 1999-04-07 EE EEP200000586A patent/EE04467B1/xx unknown
- 1999-04-07 DE DE69929315T patent/DE69929315T2/de not_active Expired - Lifetime
- 1999-04-07 EP EP99911890A patent/EP1070083B1/fr not_active Expired - Lifetime
- 1999-04-07 WO PCT/FR1999/000799 patent/WO1999052935A1/fr not_active Ceased
- 1999-07-04 UA UA2000116295A patent/UA71563C2/uk unknown
2000
- 2000-10-02 IL IL138818A patent/IL138818A/en not_active IP Right Cessation
- 2000-10-05 ZA ZA200005438A patent/ZA200005438B/en unknown
- 2000-10-06 NO NO20005060A patent/NO327995B1/no not_active IP Right Cessation
- 2000-10-06 BG BG104829A patent/BG64736B1/bg unknown
2002
- 2002-11-18 US US10/299,242 patent/US6946459B2/en not_active Expired - Lifetime
2005
- 2005-04-14 IL IL168047A patent/IL168047A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL197016B1 (pl)	2008-02-29
BR9909549A (pt)	2000-12-12
TW522152B (en)	2003-03-01
AU3041699A (en)	1999-11-01
YU60800A (sh)	2002-11-15
DK1070083T3 (da)	2006-05-15
AP2000001939A0 (en)	2000-12-31
ME01627B (me)	2008-09-29
EE200000586A (et)	2002-02-15
NO327995B1 (no)	2009-11-02
CN1305491A (zh)	2001-07-25
ZA200005438B (en)	2002-01-07
US6946459B2 (en)	2005-09-20
CZ20003678A3 (cs)	2001-02-14
EP1070083B1 (fr)	2006-01-04
CA2325629A1 (fr)	1999-10-21
ID26290A (id)	2000-12-14
SI1070083T1 (sl)	2006-04-30
JP2002511485A (ja)	2002-04-16
KR20010034759A (ko)	2001-04-25
EE04467B1 (et)	2005-04-15
HUP0101586A2 (hu)	2001-11-28
CU23055A3 (es)	2005-06-24
EA200001047A1 (ru)	2001-04-23
KR100582981B1 (ko)	2006-05-24
WO1999052935A1 (fr)	1999-10-21
BG64736B1 (bg)	2006-01-31
IL138818A (en)	2008-11-26
NZ507199A (en)	2002-12-20
DE69929315T2 (de)	2006-08-17
UA71563C2 (uk)	2004-12-15
CN1202123C (zh)	2005-05-18
HRP20000665B1 (en)	2008-01-31
SK286267B6 (sk)	2008-06-06
NO20005060D0 (no)	2000-10-06
US20030171365A1 (en)	2003-09-11
US6544977B1 (en)	2003-04-08
TR200002914T2 (tr)	2001-02-21
ATE315044T1 (de)	2006-02-15
CA2325629C (fr)	2013-01-22
RS49916B (sr)	2008-09-29
HU227561B1 (en)	2011-08-29
IL168047A (en)	2011-10-31
DE69929315D1 (de)	2006-03-30
ES2253880T3 (es)	2006-06-01
EP1070083A1 (fr)	2001-01-24
HK1038575A1 (en)	2002-03-22
AR018328A1 (es)	2001-11-14
HRP20000665A2 (en)	2001-08-31
SK14882000A3 (sk)	2001-04-09
FR2777279A1 (fr)	1999-10-15
HUP0101586A3 (en)	2002-11-28
BG104829A (en)	2001-05-31
FR2777279B1 (fr)	2004-08-13
GEP20032974B (en)	2003-05-27
AU758042B2 (en)	2003-03-13
EA002761B1 (ru)	2002-08-29
AP1734A (en)	2007-03-22
PL343350A1 (en)	2001-08-13
HK1038575B (zh)	2006-01-06
CZ299744B6 (cs)	2008-11-12

Legal Events

Date	Code	Title	Description
2018-11-26	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
HUP9902136A3 (en)	2000-03-28	Novel substituted cyclic amino acid derivatives use as pharmaceutical agents
NO986208L (no)	1998-12-30	Vandige peptidformuleringer
DK0891978T3 (da)	2002-07-01	5H-Thiazol(3,2-a)pyrimidinderivativer
NO921256D0 (no)	1992-03-31	Aminosyre-beta-lyaseenzyminhibitor som deodoranter
IT1282627B1 (it)	1998-03-31	Procedimento per la preparazione di perfluoropoliossialchileni perossidici
EP1106626A4 (en)	2001-11-28	METHOD FOR PRODUCING NORMAL GLYCOPEPTIDES
IT1272922B (it)	1997-07-01	Procedimento per la preparazione di composti metallocenici
NO20011664L (no)	2001-04-03	Sammensetning med höy renhet omfattende (7<alfa>, 17<alfa>)- 17-hydroksy-7-metyl-19-nor-17-pregn-5(10)-en-20-yn-3-on
ITMI931680A0 (it)	1993-07-28	Procedimento per la preparazione di alcansolfonammidi
IT1295934B1 (it)	1999-05-28	Procedimento migliorato per la sintesi di alchilpoliglucosidi
NO20005060D0 (no)	2000-10-06	Krystallinske former av 1S-[1<alfa>(2S,3R), 9<alfa>]6,10- diokso-N-(2-etoksy-5-okso-tetrahydro-3-furanyl)-9[[(1- isokinolyl)karbonyl]amino]oktahydro-6H-piridazino[1,2- a][1,2]diazepin-1-karboksamid
IT1292132B1 (it)	1999-01-25	Procedimento per la preparazione di diacereina
ITMI981796A0 (it)	1998-07-31	Procedimento per la preparazione di r-(-)-carnitina
IT1293819B1 (it)	1999-03-10	Procedimento per la preparazione di acarbosio
IT1267078B1 (it)	1997-01-24	Apparecchiatura per la preparazione di soluzioni
ITMI942485A0 (it)	1994-12-09	Procedimento per la preparazione di epibatidina
IT1286527B1 (it)	1998-07-15	Procedimento per la sintesi di 2-idrossi-4-alchilossi benzofenone
ITTO930667A0 (it)	1993-09-13	Procedimento per la preparazione di ethalfluralin
ITMI992457A0 (it)	1999-11-25	Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidrois ochinolin-3-carbossiammide
ITMI930340A1 (it)	1994-08-23	Procedimento per la preparazione di 5-oxo-2-pirrolidoncarbossilato di piridossina
ITMI970682A1 (it)	1998-09-26	Procedimento per la preparazione di (s)-n-terbutil-1, 2, 3, 4- tetraidroisochinolin-3- carbossiammide
ITMI932694A0 (it)	1993-12-22	Procedimento per la preparazione di 2-idrossi-1-4-noftochinoni
IT1286498B1 (it)	1998-07-15	Procedimento per la preparazione di antibiotici beta-lattamici
ITMI20000810A0 (it)	2000-04-12	Procedimento per la preparazione di 5'-acetilstavudina
IT1275450B (it)	1997-08-07	Procedimento per la preparazione di beta-idrossiidroperossidi

NO20005060L - Krystallinske former av 1S-[1<alfa>(2S*,3R*), 9<alfa>]6,10- diokso-N-(2-etoksy-5-okso-tetrahydro-3-furanyl)-9[[(1- isokinolyl)karbonyl]amino]oktahydro-6H-piridazino[1,2- a][1,2]diazepin-1-karboksamid - Google Patents